Clinical Trials

A PHASE 1/1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND IMMUNOGENICITY OF SINGLE AND MULTIPLE ASCENDING DOSES OF BCX17725 IN HEALTHY PARTICIPANTS AND MULTIPLE DOSES OF BCX17725 IN PARTICIPANTS WITH NETHERTON SYNDROME
Immune SystemCharacterization of Immune Response to Intradermal Flu Vaccination
Diseases of the Nervous SystemEvaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
ArthritisYale Rheumatology Program Patient Registry and Bio-Repository
Immune SystemYale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-RepositoryPrincipal Investigator: Fotios Koumpouras